Business

Unilever says GSK consumer arm ‘strong strategic fit’ for business


A customer chooses a Dove bar of soap, a Unilever product, at Sainsbury’s supermarket in London, UK

Bloomberg | beautiful pictures

Dove soap making machine Unilever signaled on Monday that it would pursue a deal for GlaxoSmithKline’s consumer health business, calling it a “strong strategic fit” after its £50 billion ($68.4 billion) approach was rejected.

The update comes after GSK confirmed over the weekend that it had turned down Unilever’s offer for its consumer healthcare business, which has brands like Sensodyne toothpaste and food Powersen-C vitamin supplements.

“The acquisition will create scale and growth platform for the combined portfolio in the US, China and India, with further opportunities in other emerging markets,” said Unilever. said, while also pointing to synergies in the oral care and vitamin supplement businesses.

Unilever has held talks with banks about additional financing for a potentially attractive offer for GSK’s consumer products division, Bloomberg News reported on Sunday, citing people familiar with the matter. with this problem.

Unilever, which is set to announce an initiative later this month to bolster its business, said on Monday it was committed to implementing “strict financial discipline” for any any acquisition.

.



Source link

news7f

News7F: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, Sports...at the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Back to top button